Cell & Gene Therapy 2021

Tuesday 18 May
19 May
All times shown are GMT —
DAY 1Conference HallWorkshop Room
DAY 2
09:00 09:00
09:05 09:05
09:10 09:10
09:15 09:15
09:20 09:20
09:25 09:25
09:30 09:30
09:35 09:35
09:40 09:40
09:45
Welcome and Keynote Presentation

Conference welcome and Keynote Introduction
09:45 (5 mins)
Johan Hyllner, AstraZeneca  
Combined cell and gene therapy for Epidermolysis Bullosa
09:50 (45 mins)
Keynote Speaker: Michele De Luca, Centre for Regenerative Medicine “Stefano Ferrari” University of Modena and Reggio Emillia  
Cellular reprogramming to enable the consistent and scalable manufacturing of human cells for therapeutic applications
10:35 (30 mins)
Alex Davenport — bit.bio    
09:45
09:50 09:50
09:55 09:55
10:00 10:00
10:05 10:05
10:10 10:10
10:15 10:15
10:20 10:20
10:25 10:25
10:30 10:30
10:35 10:35
10:40 10:40
10:45 10:45
10:50 10:50
10:55 10:55
11:00 11:00
11:05
Refreshment Break
11:05
11:10 11:10
11:15 11:15
11:20 11:20
11:25
Cell based therapies across disease areas - Sponsored by Iota Sciences

Session Chair Welcome
11:25 (5 mins)
Johan Hyllner, AstraZeneca  

Developing a stem cell based therapy for Parkinson’s disease
11:30 (20 mins)
Malin Parmar, Lund University  
Overcome the most common challenges in cell & gene therapy development using Droplet Digital PCR
11:50 (15 mins)
Rosario Tizzone — Bio-Rad    

Cartilage regeneration with cell therapy - current and future aspects
12:05 (20 mins)
Anders Lindahl, Institute of Biomedicine, The Sahlgrenska Academy,  
11:25
11:30 11:30
11:35 11:35
11:40 11:40
11:45 11:45
11:50 11:50
11:55 11:55
12:00 12:00
12:05 12:05
12:10 12:10
12:15 12:15
12:20 12:20
12:25
Refreshment Break
12:25
12:30
Cell based therapies across disease areas - Sponsored by Iota Sciences

Joint Q&A Session
12:30 (20 mins)
Malin Parmar, Lund University  Anders Lindahl, Institute of Biomedicine, The Sahlgrenska Academy,  
Single Cell Multiomics to Accelerate Cancer Immune Cell Therapy Research
12:50 (15 mins)
Stephen Hague — 10x Genomics    
Efficient and automated single-cell cloning with iotaSciences' cloning platform
13:05 (5 mins)
Ann Na Tan — iotaSciences    
12:30
12:35 12:35
12:40 12:40
12:45 12:45
12:50 12:50
12:55 12:55
13:00 13:00
13:05 13:05
13:10
Refreshment Break, Poster Session & Vendor Exhibition
Workshop hosted by Miltenyi Biotec Ltd
Virtual demo – Automate adherent cell manufacturing
13:10 (60 mins)
Chao Sheng — Miltenyi Biotec    
13:10
13:15 13:15
13:20 13:20
13:25 13:25
13:30 13:30
13:35 13:35
13:40 13:40
13:45 13:45
13:50 13:50
13:55 13:55
14:00 14:00
14:05 14:05
14:10
Cell based therapies across disease areas - Sponsored by Iota Sciences

Session Chair Welcome
14:10 (5 mins)
Ryan Hicks, AstraZeneca  

Is the Cellular Secretome the Next Step of Cell Therapy?
14:15 (20 mins)
Philippé Menasché, INSERM  
Streamline and modernise your Immunology and Immuno-Oncology research
14:35 (30 mins)
Suzanne Riches — Nexcelom from PerkinElmer     
14:10
14:15 14:15
14:20 14:20
14:25 14:25
14:30 14:30
14:35 14:35
14:40 14:40
14:45 14:45
14:50 14:50
14:55 14:55
15:00 15:00
15:05
Cell based therapies across disease areas - Sponsored by Iota Sciences

VEGF-A modified mRNA in Cardiovascular Disease
15:05 (20 mins)
Anna Collén, AstraZeneca  
15:05
15:10 15:10
15:15 15:15
15:20 15:20
15:25
Refreshment Break
15:25
15:30
Cell based therapies across disease areas - Sponsored by Iota Sciences

Regenerative Medicine in Diabetes: a work in progress
15:30 (20 mins)
Lorenzo Piemonti , IRCCS Ospedale San Raffaele  

Joint Q&A Session
15:50 (20 mins)
Philippé Menasché, INSERM  Anna Collén, AstraZeneca  Lorenzo Piemonti , IRCCS Ospedale San Raffaele  
15:30
15:35 15:35
15:40 15:40
15:45 15:45
15:50 15:50
15:55 15:55
16:00 16:00
16:05 16:05
16:10 16:10
16:15 16:15
16:20 16:20
16:25 16:25
16:30 16:30
16:35 16:35
16:40 16:40
16:45 16:45
16:50 16:50
16:55 16:55
17:00 17:00